iifl-logo

Akums Drugs & Pharmaceuticals Ltd Quarterly Results

530.6
(0.12%)
Apr 25, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Financials

Particulars (Rupees in Crores.)Dec-2024Sept-2024Jun-2024Mar-2024Dec-2023

Gross Sales

1,010.41

1,033.09

1,019.11

944.21

1,082.84

Excise Duty

0

0

0

0

0

Net Sales

1,010.41

1,033.09

1,019.11

944.21

1,082.84

Other Operating Income

0

0

0

0

0

Other Income

19.34

17.17

6.55

10.46

9.83

Total Income

1,029.75

1,050.26

1,025.66

954.67

1,092.67

Total Expenditure

889.05

911.9

891.1

941.22

989.4

PBIDT

140.71

138.35

134.56

13.45

103.26

Interest

5.13

11.9

13.02

12.38

12.44

PBDT

135.57

126.45

121.54

1.07

90.83

Depreciation

44.52

34.87

34.06

33.95

31.55

Minority Interest Before NP

0

0

0

0

0

Tax

19.8

21.95

18.76

8.09

6.04

Deferred Tax

4.95

2.99

7.52

-1.5

-141.76

Reported Profit After Tax

66.31

66.65

61.21

-39.47

195

Minority Interest After NP

1.13

1.45

1.04

1.85

1.3

Net Profit after Minority Interest

65.18

65.21

60.17

-41.32

193.7

Extra-ordinary Items

3.48

2.69

0

0.16

0.82

Adjusted Profit After Extra-ordinary item

61.7

62.52

60.17

-41.48

192.88

EPS (Unit Curr.)

4.26

4.37

4.21

-2.89

13.21

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

30.62

30.62

28.61

28.61

28.61

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

13.92

13.39

13.2

1.42

9.53

PBDTM(%)

13.41

12.23

11.92

0.11

8.38

PATM(%)

6.56

6.45

6

-4.18

18

Akums Drugs & Pharmaceuticals Ltd: Related NEWS

Akums Drugs & Pharm a shares close at a 17% premium
6 Aug 2024|03:43 PM

The organisation is the largest CDMO serving the Indian pharmaceutical industry, with a proven track record and a broad clientele.

Read More
Akums Drugs Lists With 6% Premium
6 Aug 2024|09:56 AM

The IPO comprised a fresh issue of shares worth ₹680 crore and an offer-for-sale (OFS) of 1.73 crore shares, aggregating ₹1,177 crore.

Read More
Akums Drugs & Pharma IPO subscribed 43 times so far
1 Aug 2024|03:26 PM

The IPO consists of a fresh issue of ₹680 crore and an offer for sale (OFS) of up to 1.73 crore shares at a face value of ₹2 each.

Read More
Akums Drugs IPO Subscribed 3.20 times so far Day 2
31 Jul 2024|03:48 PM

On Monday, the business said that it had received ₹829 crore from anchor investors ahead of the public share sale subscription period.

Read More
Akums Drugs and Pharmaceuticals IPO subscribed 97%
30 Jul 2024|03:09 PM

The IPO includes a new issue of 1 Crore shares worth ₹680.00 Crore and an offer for sale of 1.73 Crore shares worth ₹1,176.74 Crore.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.